{"id":5649,"date":"2014-05-26T09:00:00","date_gmt":"2014-05-26T09:00:00","guid":{"rendered":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/jdrf-nederland-vertegenwoordigt-bij-belangrijk-overleg-brussel\/"},"modified":"2024-09-23T11:22:42","modified_gmt":"2024-09-23T11:22:42","slug":"jdrf-nederland-vertegenwoordigt-bij-belangrijk-overleg-brussel","status":"publish","type":"post","link":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/jdrf-nederland-vertegenwoordigt-bij-belangrijk-overleg-brussel\/","title":{"rendered":"Breakthrough T1D Nederland bij belangrijk overleg in Brussel"},"content":{"rendered":"<p>Op 20 mei jl. vond in Brussel de IMI \u2013 Breakthrough T1D Diabetes Patient Focus Meeting plaats. Deze bijeenkomst, georganiseerd door IMI (Innovative Medicines Initiative) en Breakthrough T1D, had als doel om vanuit het perspectief van mensen met Type 1 Diabetes (T1D) te kijken op welke gebieden diabetesonderzoek tekort schiet en vooral hoe deze gaten opgevuld kunnen worden. De behoeften van de pati\u00ebnt en de uitdagingen die zijn in hun dagelijks leven tegenkomen stonden hierbij centraal.<\/p>\n<p> IMI en Breakthrough T1D organiseerden deze meeting om bij het Europees Parlement aandacht te vragen voor T1D, en fondsen te werven voor T1D-onderzoek. Het Europees Parlement zou veel geld kunnen bijdragen aan onderzoek en zo een wereld zonder T1D weer een stapje dichterbij kunnen brengen.<\/p>\n<p> Merijn de Groot, jeugdambassadeur van Breakthrough T1D Nederland, en Johan Keurentjes, bestuurslid van Breakthrough T1D Nederland en lid van de internationale T1D Voices Council spraken tijdens deze bijeenkomst over hun leven met T1D.<\/p>\n<p><i>\u201cEr is nog enorm veel terrein te winnen bij het centraal stellen van de pati\u00ebnten (de doelgroep) bij het selecteren en uitvoeren van onderzoek. De bijeenkomst gaf ons een goed podium om onze ervaringen en wensen op dit gebied aan een breed internationaal publiek te presenteren. Bij Breakthrough T1D hebben pati\u00ebnten en ouder een zeer prominente rol. Na deze dag verwacht ik dat we (de pati\u00ebnten) ook bij de besteding van de onderzoeksgelden uit Europa een belangrijker rol gaan spelen.\u201d &#8211; Johan Keurentjes<\/i><\/p>\n<p> De bijeenkomst was een initiatief van Breakthrough T1D en IMI. IMI is een samenwerkingsverband tussen de Europese unie en de farmaceutische industrie. Met betrekking tot diabetes heeft IMI een diabetesplatform opgezet, waar momenteel drie Europese projecten in samenwerken om nieuwe oplossingen te vinden voor beter diabetesmanagement.<\/p>","protected":false,"raw":""},"excerpt":{"rendered":"<p>Op 20 mei jl. vond in Brussel de IMI \u2013 Breakthrough T1D Diabetes Patient Focus Meeting plaats. Deze bijeenkomst, georganiseerd door IMI (Innovative Medicines Initiative) en Breakthrough T1D, had als doel om vanuit het perspectief van mensen met Type 1 Diabetes (T1D) te kijken op welke gebieden diabetesonderzoek tekort schiet en vooral hoe deze gaten [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[184],"tags":[],"class_list":["post-5649","post","type-post","status-publish","format-standard","hentry","category-archief"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Breakthrough T1D Nederland bij belangrijk overleg in Brussel - Breakthrough T1D<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/jdrf-nederland-vertegenwoordigt-bij-belangrijk-overleg-brussel\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Breakthrough T1D Nederland bij belangrijk overleg in Brussel - Breakthrough T1D\" \/>\n<meta property=\"og:description\" content=\"Op 20 mei jl. vond in Brussel de IMI \u2013 Breakthrough T1D Diabetes Patient Focus Meeting plaats. Deze bijeenkomst, georganiseerd door IMI (Innovative Medicines Initiative) en Breakthrough T1D, had als doel om vanuit het perspectief van mensen met Type 1 Diabetes (T1D) te kijken op welke gebieden diabetesonderzoek tekort schiet en vooral hoe deze gaten [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/jdrf-nederland-vertegenwoordigt-bij-belangrijk-overleg-brussel\/\" \/>\n<meta property=\"og:site_name\" content=\"Breakthrough T1D\" \/>\n<meta property=\"article:published_time\" content=\"2014-05-26T09:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-23T11:22:42+00:00\" \/>\n<meta name=\"author\" content=\"ylt-admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschreven door\" \/>\n\t<meta name=\"twitter:data1\" content=\"ylt-admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/jdrf-nederland-vertegenwoordigt-bij-belangrijk-overleg-brussel\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/jdrf-nederland-vertegenwoordigt-bij-belangrijk-overleg-brussel\/\"},\"author\":{\"name\":\"ylt-admin\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6\"},\"headline\":\"Breakthrough T1D Nederland bij belangrijk overleg in Brussel\",\"datePublished\":\"2014-05-26T09:00:00+00:00\",\"dateModified\":\"2024-09-23T11:22:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/jdrf-nederland-vertegenwoordigt-bij-belangrijk-overleg-brussel\/\"},\"wordCount\":306,\"publisher\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\"},\"articleSection\":[\"Archief\"],\"inLanguage\":\"nl-NL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/jdrf-nederland-vertegenwoordigt-bij-belangrijk-overleg-brussel\/\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/jdrf-nederland-vertegenwoordigt-bij-belangrijk-overleg-brussel\/\",\"name\":\"Breakthrough T1D Nederland bij belangrijk overleg in Brussel - Breakthrough T1D\",\"isPartOf\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#website\"},\"datePublished\":\"2014-05-26T09:00:00+00:00\",\"dateModified\":\"2024-09-23T11:22:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/jdrf-nederland-vertegenwoordigt-bij-belangrijk-overleg-brussel\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/jdrf-nederland-vertegenwoordigt-bij-belangrijk-overleg-brussel\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/jdrf-nederland-vertegenwoordigt-bij-belangrijk-overleg-brussel\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/breakthrought1d.eu\/nl\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Breakthrough T1D Nederland bij belangrijk overleg in Brussel\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#website\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/\",\"name\":\"Breakthrough T1D\",\"description\":\"Wij zetten ons in voor een toekomst zonder T1D\",\"publisher\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\",\"name\":\"Breakthrough T1D\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png\",\"contentUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png\",\"width\":330,\"height\":141,\"caption\":\"Breakthrough T1D\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6\",\"name\":\"ylt-admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"caption\":\"ylt-admin\"},\"sameAs\":[\"https:\/\/87.250.144.92\"],\"url\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Breakthrough T1D Nederland bij belangrijk overleg in Brussel - Breakthrough T1D","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/jdrf-nederland-vertegenwoordigt-bij-belangrijk-overleg-brussel\/","og_locale":"nl_NL","og_type":"article","og_title":"Breakthrough T1D Nederland bij belangrijk overleg in Brussel - Breakthrough T1D","og_description":"Op 20 mei jl. vond in Brussel de IMI \u2013 Breakthrough T1D Diabetes Patient Focus Meeting plaats. Deze bijeenkomst, georganiseerd door IMI (Innovative Medicines Initiative) en Breakthrough T1D, had als doel om vanuit het perspectief van mensen met Type 1 Diabetes (T1D) te kijken op welke gebieden diabetesonderzoek tekort schiet en vooral hoe deze gaten [&hellip;]","og_url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/jdrf-nederland-vertegenwoordigt-bij-belangrijk-overleg-brussel\/","og_site_name":"Breakthrough T1D","article_published_time":"2014-05-26T09:00:00+00:00","article_modified_time":"2024-09-23T11:22:42+00:00","author":"ylt-admin","twitter_card":"summary_large_image","twitter_misc":{"Geschreven door":"ylt-admin","Geschatte leestijd":"1 minuut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/jdrf-nederland-vertegenwoordigt-bij-belangrijk-overleg-brussel\/#article","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/jdrf-nederland-vertegenwoordigt-bij-belangrijk-overleg-brussel\/"},"author":{"name":"ylt-admin","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6"},"headline":"Breakthrough T1D Nederland bij belangrijk overleg in Brussel","datePublished":"2014-05-26T09:00:00+00:00","dateModified":"2024-09-23T11:22:42+00:00","mainEntityOfPage":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/jdrf-nederland-vertegenwoordigt-bij-belangrijk-overleg-brussel\/"},"wordCount":306,"publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"articleSection":["Archief"],"inLanguage":"nl-NL"},{"@type":"WebPage","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/jdrf-nederland-vertegenwoordigt-bij-belangrijk-overleg-brussel\/","url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/jdrf-nederland-vertegenwoordigt-bij-belangrijk-overleg-brussel\/","name":"Breakthrough T1D Nederland bij belangrijk overleg in Brussel - Breakthrough T1D","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#website"},"datePublished":"2014-05-26T09:00:00+00:00","dateModified":"2024-09-23T11:22:42+00:00","breadcrumb":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/jdrf-nederland-vertegenwoordigt-bij-belangrijk-overleg-brussel\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/breakthrought1d.eu\/nl\/nieuws\/jdrf-nederland-vertegenwoordigt-bij-belangrijk-overleg-brussel\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/jdrf-nederland-vertegenwoordigt-bij-belangrijk-overleg-brussel\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/breakthrought1d.eu\/nl\/"},{"@type":"ListItem","position":2,"name":"Breakthrough T1D Nederland bij belangrijk overleg in Brussel"}]},{"@type":"WebSite","@id":"https:\/\/breakthrought1d.eu\/nl\/#website","url":"https:\/\/breakthrought1d.eu\/nl\/","name":"Breakthrough T1D","description":"Wij zetten ons in voor een toekomst zonder T1D","publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/breakthrought1d.eu\/nl\/#organization","name":"Breakthrough T1D","url":"https:\/\/breakthrought1d.eu\/nl\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/","url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","contentUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","width":330,"height":141,"caption":"Breakthrough T1D"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6","name":"ylt-admin","image":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","caption":"ylt-admin"},"sameAs":["https:\/\/87.250.144.92"],"url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/"}]}},"_links":{"self":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5649","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/comments?post=5649"}],"version-history":[{"count":1,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5649\/revisions"}],"predecessor-version":[{"id":7198,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5649\/revisions\/7198"}],"wp:attachment":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/media?parent=5649"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/categories?post=5649"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/tags?post=5649"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}